Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Medtronic's arrhythmia management device enters clinic

Jan. 20, 1997

Terumo prepares smooth muscle cell proliferation inhibitors

Jan. 17, 1997

Sigma-Tau reports therapeutically active seco-D steroid derivatives

Jan. 17, 1997

February review for Medco's vasodilator combination

Jan. 16, 1997

Long-acting calcium channel blocker proves effective in post-MI patients

Jan. 16, 1997

cGMP PDE inhibitors from Taisho

Jan. 14, 1997

Nitric oxide synthase inhibitors reported by Searle

Jan. 14, 1997

Genzyme announces launch of instrument line

Jan. 10, 1997

Hyal receives notice of allowance for cardiovascular applications of hyaluronic acid

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...